Webcast

Universal Biosensors Investor Briefing – 18 August

August 18, 2021

Universal Biosensors Investor Briefing – 18 August

Universal Biosensor (ASX: UBI) Webcast Replay

18th August, 2021

Universal Biosensors (ASX: UBI) specialises in the research, design and development of devices for the diagnostic point of care market. 

As a part of our ‘The Insiders: Meet the CEOs’ series, CEO John Sharman, provides valuable insights to the company, its key markets and industry, and future prospects.

Recorded on 18 August 2021 at 12pm (AEST).

Join the next The Insider: Meet the CEOs webcast

Speak to the Reach Markets team

FEATURED SPEAKER

John Sharman

Chief Executive Officer - Universal Biosensors (ASX: UBI)

Universal Biosensors (ASX: UBI) specialises in the research, design and development of devices for the diagnostic point of care market. UBI’s core technology is a disposable, multi-layer test strip, which incorporates a proprietary electrochemical sensing system that rapidly and accurately measures different biomarkers in blood. UBI’s technology platform has delivered more than 10 billion diagnostic tests to patients worldwide in glucose and coagulation products.

Speak to the Reach Markets team




What is a 708 investor?

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.